HIP
ALT icon

HUB Investment Partners’s Altimmune ALT Stock Holding History

HUB Investment Partners’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$93.1K Buy
30,218
+16,000
+113% +$67.9K ﹤0.01% 1069
2025
Q4 		$51.3K Buy
+14,218
New +$62K ﹤0.01% 933

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HUB Investment Partners's ALT Position: Q1 2026 in Review

HUB Investment Partners increased its Altimmune (ALT) stake by 113% in Q1 2026, buying an estimated $67.9K and bringing the position to 30,218 shares worth $93.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1069.

HUB Investment Partners first reported a position in ALT in Q4 2025 and has held it in 2 quarters since. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • HUB Investment Partners held 30,218 shares of Altimmune worth $93.1K as of Q1 2026.
  • HUB Investment Partners bought 16,000 Altimmune shares in Q1 2026, an estimated $67.9K.
  • Altimmune made up ﹤0.01% of HUB Investment Partners's portfolio in Q1 2026, its #1069 holding.
  • HUB Investment Partners first reported a position in Altimmune in Q4 2025 and has held it in 2 quarters since.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on HUB Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.